Clinical Trial Update: A Multi-center, Placebo-controlled Study to Evaluate the Safety of GSK716155 and Its Effects on Myocardial Metabolism, Myocardial Function, and Exercise Capacity in Patients With NYHA Class II/III Congestive Heart Failure [Phase 2]

View source ↗

Summary

A Phase 2 multi-center, placebo-controlled trial evaluated the safety, myocardial metabolism, function, and exercise capacity effects of GSK716155 in patients w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• GSK716155

Snippet

Sponsor: GlaxoSmithKline | Conditions: Heart Failure, Congestive | Phase 2 | Status: COMPLETED | Results posted: 2014-10-01